NovaBay Pharmaceuticals to Hold Second Quarter 2016 Conference Call on August 11
August 04 2016 - 6:50AM
Business Wire
NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a
biopharmaceutical company focusing on commercializing its
prescription Avenova® lid and lash hygiene product for the domestic
eye care market, announces that it will report second quarter 2016
financial results after market close on Thursday, August 11.
Management will hold an investment community conference call that
day to discuss financial results and provide a Company update.
DATE: Thursday, August 11 TIME: 4:30 p.m. ET /
1:30 p.m. PT DIAL IN: 800-608-8202 from within the U.S.
702-495-1913 from outside the U.S. Enter conference identification
number 54133101
The live call also will be available at
http://novabay.com/investors/events. A replay of the call will be
available beginning two hours after its completion through 11:59
p.m. Eastern time August 15, 2016, by dialing 855-859-2056 from
within the U.S. or 404-537-3406 from outside the U.S. and entering
the conference identification number 54133101. The call will also
be archived at http://novabay.com/investors/events.
About NovaBay Pharmaceuticals, Inc.: Going Beyond
Antibiotics®
NovaBay Pharmaceuticals is a biopharmaceutical company focusing
on the commercialization of prescription Avenova® lid and lash
hygiene for the domestic eye care market. Avenova is formulated
with Neutrox® which is cleared by the U.S. Food and Drug
Administration (FDA) as a 510(k) medical device. Neutrox is
NovaBay’s proprietary pure hypochlorous acid. Laboratory tests show
that hypochlorous acid has potent antimicrobial activity in
solution yet is non-toxic to mammalian cells and it also
neutralizes bacterial toxins. Avenova is marketed to optometrists
and ophthalmologists throughout the U.S. by NovaBay’s direct
medical salesforce. It is accessible from more than 90% of retail
pharmacies in the U.S. through agreements with McKesson
Corporation, Cardinal Health and AmeriSource Bergen.
Stay informed on NovaBay's
progress:
Download our Mobile InvestorApp from the Apple
Store or Google PlayLike us on
FacebookFollow us on TwitterConnect with
NovaBay on LinkedInJoin us on
Google+Visit NovaBay's Website
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160804005062/en/
NovaBay ContactsFor NovaBay
Avenova purchasing information, please contact:Email usCall us:
1-800-890-0329www.Avenova.comorFrom the
CompanyThomas J. Paulson, 510-899-8809Chief Financial
OfficerContact TomorInvestor
ContactLHAJody Cain, 310-691-7100jcain@lhai.com
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Aug 2024 to Sep 2024
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Sep 2023 to Sep 2024